pubmed-article:8303635 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8303635 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
pubmed-article:8303635 | lifeskim:mentions | umls-concept:C0085504 | lld:lifeskim |
pubmed-article:8303635 | lifeskim:mentions | umls-concept:C0085393 | lld:lifeskim |
pubmed-article:8303635 | lifeskim:mentions | umls-concept:C0600367 | lld:lifeskim |
pubmed-article:8303635 | lifeskim:mentions | umls-concept:C1512656 | lld:lifeskim |
pubmed-article:8303635 | pubmed:issue | 12 | lld:pubmed |
pubmed-article:8303635 | pubmed:dateCreated | 1994-3-10 | lld:pubmed |
pubmed-article:8303635 | pubmed:abstractText | Chlamydia pneumoniae is drawing increasing attention as an agent of respiratory tract infection. Specific antibody prevalence in western countries is low in preschool children and reaches more than 50% in adults. However, little is known about the prevalence of this infection in immunocompromised subjects such as HIV-I infected patients. The aim of this study was to evaluate the seroprevalence of Chl pneumoniae in immunocompetent and immunocompromised (HIV-1 infected) paediatric and adult populations. | lld:pubmed |
pubmed-article:8303635 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8303635 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8303635 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8303635 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8303635 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8303635 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8303635 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8303635 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8303635 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8303635 | pubmed:language | eng | lld:pubmed |
pubmed-article:8303635 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8303635 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8303635 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8303635 | pubmed:month | Dec | lld:pubmed |
pubmed-article:8303635 | pubmed:issn | 0040-6376 | lld:pubmed |
pubmed-article:8303635 | pubmed:author | pubmed-author:AllegraLL | lld:pubmed |
pubmed-article:8303635 | pubmed:author | pubmed-author:LupoAA | lld:pubmed |
pubmed-article:8303635 | pubmed:author | pubmed-author:BlasiFF | lld:pubmed |
pubmed-article:8303635 | pubmed:author | pubmed-author:CosentiniRR | lld:pubmed |
pubmed-article:8303635 | pubmed:author | pubmed-author:SchoellerM... | lld:pubmed |
pubmed-article:8303635 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8303635 | pubmed:volume | 48 | lld:pubmed |
pubmed-article:8303635 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8303635 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8303635 | pubmed:pagination | 1261-3 | lld:pubmed |
pubmed-article:8303635 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:meshHeading | pubmed-meshheading:8303635-... | lld:pubmed |
pubmed-article:8303635 | pubmed:year | 1993 | lld:pubmed |
pubmed-article:8303635 | pubmed:articleTitle | Chlamydia pneumoniae seroprevalence in immunocompetent and immunocompromised populations in Milan. | lld:pubmed |
pubmed-article:8303635 | pubmed:affiliation | Institute of Respiratory Diseases, University of Milan, Italy. | lld:pubmed |
pubmed-article:8303635 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8303635 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8303635 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8303635 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8303635 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8303635 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8303635 | lld:pubmed |